Sanofi to build new manufacturing facility in Toronto

By The Science Advisory Board staff writers

April 1, 2021 -- Sanofi announced an investment of approximately $737 million U.S. in a new vaccine manufacturing facility at its existing site in Toronto, Canada, to provide additional antigen and filling capacity for Sanofi's influenza vaccine.

The investment is intended to strengthen domestic pandemic preparedness and increase global supply of Sanofi's Fluzone high-dose quadrivalent influenza vaccine, which has been recommended for use over standard-dose influenza vaccines in individual adults 65 years and older by the National Advisory Committee on Immunization in Canada.

The Sanofi Pasteur site currently manufactures millions of doses of vaccines annually against pertussis, polio, diphtheria, and tetanus, among others, for more than 60 countries worldwide. Vaccines produced at the new facility on the same site will supply influenza vaccines to Canada, the U.S., and Europe.

Following design, construction, testing, and qualification of the facility and equipment, the new facility will be operational by 2026. The investment will create 300 high quality jobs, according to the company.

Copyright © 2021

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for

Email Preferences

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.